SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules is a research paper published in Scientific Reports (2017). On theSindex it has a DataRank of 1.5. It has been cited 16,489 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.5
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
340.91
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors
Additional file 1 of Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors
Additional file 1 of The drug likeness analysis of anti-inflammatory clerodane diterpenoids
Additional file 1 of The drug likeness analysis of anti-inflammatory clerodane diterpenoids
Additional file 1 of Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents
Additional file 1 of Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents
Additional file 1 of Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line
Additional file 1 of Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line
Additional file 1 of Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection
Additional file 1 of Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection
Additional file 1 of Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach
Additional file 1 of Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach
Additional file 1 of Diversity-oriented synthesis derived indole based spiro and fused small molecules kills artemisinin-resistant Plasmodium falciparum
Additional file 1 of Diversity-oriented synthesis derived indole based spiro and fused small molecules kills artemisinin-resistant Plasmodium falciparum
Additional file 1 of Non-target metabolomics revealed the differences between Rh. tanguticum plants growing under canopy and open habitats
Additional file 1 of Non-target metabolomics revealed the differences between Rh. tanguticum plants growing under canopy and open habitats
Additional file 1 of Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents
Additional file 1 of Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents
Additional file 1 of Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies
Additional file 1 of Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies